Podcast - What Are Joint Ventures and When Should They Get Cleared?
Episode 319 -- Deep Dive into SCG Plastics' $20 Million Settlement with OFAC for Violations of the Iran Sanctions Program
Joint Venture Basics for Large and Small Contractors
Bidding for Major Contracts? Compliance Requirements You Should Prepare for Now
Marriages don't last forever: How to terminate a Joint Venture - and come out of it relatively unscathed. Podcast episode 2
Marriages don't last forever - When Joint Ventures go wrong. Podcast episode 1
Construction Webinar Series: Building Compliance: Construction Industry Concerns Under FCA
Ashley Coselli and Daniel Wendt on Difficult Anti-Corruption Due Diligence Projects
Teeming with Teaming Agreements: Navigating Strategic Alliances in the Federal Marketplace
CIO-SP4 Is Ready To Launch: Is Your Business Equipped to Compete?
Roadmap to Joint Venture Agreements: Legal and Accounting Considerations
M&A Webinar - Trendspotting: The Rise of the Atypical Deal
SBA’s Final Rule on SBA’s MP Program, Joint Ventures, Affiliation and 8(a) Regulations
SBA’s Final Rule on Mentor-Protégé Programs: Key Changes for Government Contractors
Growth Strategies for Small Businesses Moving to Mid-Tier
Shoot for the STARS: Q&A with SBA’s John Klein on GSA's 8(a) STARS III RFP
Williams Mullen's COVID-19 Comeback Plan: Selling Products and Services to the Federal Government
Day 18 of One Month to More Effective Compliance for Business Ventures-Financial Review of Your Business Venture Partner
Day 15 of One Month to More Effective Compliance for Business Ventures- Tying It All Together for Joint Ventures
Day 14 of One Month to More Effective Compliance for Business Ventures-Auditing Joint Ventures
Globally, market volatility has eroded confidence and subdued M&A activity. A “wait and see” approach is the prevailing sentiment for many market participants; it is difficult to convince boards to advance deals while...more
Hosted by the American Conference Institute, the 19th Annual FCPA & Anti-Corruption Conference for the Life Sciences Industry returns for another exciting year with carefully researched programming based on critical findings...more
Welcome to the first edition of our European Healthcare & Life Sciences Market Update, a new report summarising key emerging trends, opportunities, and challenges facing the market in 2022. During the last 12 months, the...more
Across the US and EU, life sciences companies are pushing diagnostics, antibody testing, vaccines and other efforts forward to flatten the Coronavirus (COVID-19) curve. Our multidisciplinary cross-border life sciences team...more
Despite political and economic uncertainties, markets and deal activity were resilient in 2019, and strong fundamentals remain in place heading into 2020. Companies continue to face a challenging litigation and enforcement...more